Oral ivermectin for a scabies outbreak in a long‐term care facility: potential value in preventing COVID‐19 and associated mortality
Charlotte Bernigaud, Didier Guillemot, Abdelhakim Ahmed‐Belkacem, Lamiae Grimaldi‐Bensouda, Anne Lespine, François Berry, Laurent Softic, C. Chenost, G. Do–Pham, Bruno Giraudeau, Slim Fourati, O. Chosidow
Abstract
International audience
Topics & Concepts
IvermectinMoxidectinOutbreakCase fatality rateAntiparasitic agentMedicinePopulationScabiesPandemicCoronavirus disease 2019 (COVID-19)Long-term careIntensive care medicineEnvironmental healthDiseaseVeterinary medicineInternal medicineVirologyDermatologyInfectious disease (medical specialty)NursingDermatological diseases and infestationsParasites and Host InteractionsDental Research and COVID-19